Results 151 to 160 of about 9,061 (176)
Some of the next articles are maybe not open access.
Overall survival with abemaciclib in early breast cancer☆
Background: Adjuvant abemaciclib combined with endocrine therapy (ET) significantly improved invasive disease-free survival (IDFS) in patients with hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative, node-positive, high-risk ...
Laura Testa +2 more
exaly +2 more sources
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib
European Journal of Clinical Pharmacology, 2022Hitoshi Ando +2 more
exaly
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer
Cancer, 2022Nathan Watson +2 more
exaly

